MCDC 25-01 Innovative Drug Development Pipeline Methods for Rapid Medical Countermeasure (MCM) Development This solicitation from the Medical CBRN Defense Consortium (MCDC), in support of the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) represents a Request for Prototype Proposals (RPP). This RPP (MCDC 25-01) calls for innovative drug development pipeline […]
MCDC Requests Prototype Projects Read More »
Evaluation Criteria White Paper Template W911SR-24-S-HDTX+RFI The Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical (JPM CBRN Medical), along with the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND), invites stakeholders from industry, academia, and nonprofit sectors to submit white papers for the development and repurposing of host-directed therapeutics.
JPM & JPEO Issues RFI for Host-Directed Therapeutics for Prophylaxis Read More »
A Guide to JPEO Funding: Application Process, Financial and Technical Requirements In the complex ecosystem of defense and homeland security, the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) holds a distinct role. This specialized office under the Department of Defense (DoD) focuses on safeguarding the United States military and its
A Guide to JPEO Funding Read More »
The Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) has recently issued a Request for Information (RFI) aimed at market research and planning. The primary objective of this RFI is to identify potential vendors capable of providing advanced genomic sequencing and/or associated sample preparation capabilities. The JPEO-CBRND is particularly interested in
New JPEO RFI for Advanced Genomic Sequencing and In-field Sample Preparation Read More »
